malaria

Discovery of Malaria parasite behaviour offers new target for treatment

Scandinavian scientists explain the mechanisms behind the protection that blood type O provides

Scientists have discovered why infections with the two most common types of malaria parasite combined lead to greater health risks - because one species helps the other to thrive

Demand for antimalarial medicines will grow from 1.3bn treatments in 2015 to approximately 1.4bn treatments by 2018

Results from exploratory Phase I/II clinical trial in uncomplicated malaria

Report highlights barriers - including high prices, patents, and the lack of adapted formulations

International researchers have identified how malaria parasites growing inside red blood cells stick to the sides of blood vessels in severe cases of malaria.

A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world.

Researchers developed techniques to quickly identify evolution of drug resistance in strains of malaria. Their goal is to enable the medical community to react quickly to inevitable resistance.

Using an experimental mouse model for malaria, an international group of scientists has discovered that adding antioxidant therapy to traditional antimalarial treatment may prevent long-lasting cognitive impairment in cerebral malaria.

Inconspicuous "little brown balls" in the ocean have helped settle a long-standing debate about the origin of malaria and the algae responsible for toxic red tides, according to a new study.

Researchers seeking to block invasion of healthy red blood cells by malaria parasites have instead succeeded in locking the parasites within infected blood cells, potentially containing the disease.

A researcher has highlighted the poor quality of published studies that evaluate the accuracy of diagnostic tests for 3 major killer infectious diseases (TB, HIV/AIDS and malaria).

A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania.

The prospects for an effective vaccine for malaria are considerably better since the discovery that healthy volunteers can be fully protected against malaria.

Scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease.

Variation in the same gene affects rate of parasite infection in both humans and baboons and may connect important genetic variation to malaria resistance.

Researchers have discovered one way to stop malaria parasite growth, and this new finding could guide the development of new malaria treatments.

Researchers have discovered that parasites hijack host-cell proteins to ensure their survival and proliferation, suggesting new ways to control the diseases they cause.

A researcher at the University of Southampton believes the global eradication of malaria could be achieved by individual countries eliminating the disease within their own borders and coordinating efforts regionally.